Sage Therapeutics (SAGE) PT Raised to $123 at Leerink Partners
Tweet
Share
E-mail
Get Alerts SAGE Hot Sheet
Price: $8.68 --0%
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
Leerink Partners analyst Paul Matteis raised its price target on Sage Therapeutics (NASDAQ: SAGE) to $123.00 (from $85.00) while maintaining an Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EssilorLuxottica SA (EL:FP) (ESLOY) PT Lowered to EUR181 at Deutsche Bank
- JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
- BioMerieux (BIM:FP) (BMXMF) PT Lowered to EUR80 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
